Population-Specific Polygenic Risk Scores Developed for the Han Chinese
Hung-Hsin Chen,Chien-Hsiun Chen,Ming-Chih Hou,Yun-Ching Fu,Ling-Hui Li,Che-Yu Chou,Erh-Chan Yeh,Ming-Fang Tsai,Chun-houh Chen,Hsin-Chou Yang,Yen-Tsung Huang,Yi-Min Liu,Chun-yu Wei,Jen-Ping Su,Wan-Jia Lin,Elin H.F. Wang,Chi-Lu Chiang,Jeng-Kai Jiang,I-Hui Lee,Kung-Hao Liang,Wei-Sheng Chen,Hung-Cheng Tsai,Shih-Yao Lin,Fu-Pang Chang,Hsiang-Ling Ho,Yi-Chen Yeh,Wei-Cheng Tseng,Ming-Hwai Lin,Hsiao-Ting Chang,Ling-Ming Tseng,Wen-Yih Liang,Paul Chih-Hsueh Chen,Yu-Cheng Hsieh,Yi-Ming Chen,Tzu-Hung Hsiao,Ching_Heng Lin,Yen-Ju Chen,I-Chieh Chen,Chien-Lin Mao,Shu-Jung Chang,Yen-Lin Chang,Yi_Ju Liao,Chih-Hung Lai,Wei-Ju Lee,Hsin Tung,Ting-Ting Yen,Hsin-Chien Yen,Ming-Yao Chen,Ying-Chin Lin,Yung-Ta Kao,Bi-Zhen Kao,Jing-Er Lee,Chi-Li Chung,Ju-Chi Liu,Paul Chan,Chang-Hsien Lin,Chia-Hsin Chen,I-Chen Wu,Lung-Chang Lin,Jiunn-Wei Wang,Shen-liang Shih,Sun-Wung Hsieh,Chih-Hsing Hung,Wei-Ming Li,Chih-Jen Yang,Cheng-Shin Yang,Ru-Hui Weng,Yu-Chi Chen,Chun-Ping Chang,Tai-Hsun Wu,Yu-Chang Lin,Yi-Jing Sheen,Shi-Heng Wang,Sye-Pu Chen,Timothy Raben,Erik Widen,Stephen Hsu,Feng-Jen Hsieh,Dong-Ru Ho,Yu-Huei Huang,Chung-Han Yang,Yu-Shu Huang,Yen-Fu Chen,Hsien-Ming Wu,Ping-Han Tsai,Kuan-Gen Huang,Chih-Yen Chien,Yi-Lwun Ho,Ming-Shiang Wu,Jia-Horng Kao,Yen-Bin Liu,Jyh-Ming Jimmy Juang,Mao-Hsin Lin,Yen-Hung Lin,Ji-Yuh Lee,Hsueh-Ju Lu,Chieh-Hua Lu,An-Chieh Feng,Jhih-Syuan Liu,Chien-Ping Chiang,Nain-Feng Chu,Jung-Chun Lin,Yi-Wei Yeh,En Meng,Chih-Yang Huang,Chi-Cheng Li,Tso-Fu Wang,Kuei-Ying Su,Jia-Kang Wang,Mei-Hsiu Chen,Hua-Fen Chen,Gwo-Chin Ma,Ting-Yu Chang,Fu-Tien Chiang,Hsing-Jung Chang,Kuo-Jang Kao,Chen-Fang Hung,Ching-Yao Tsai,Po-Yueh Chen,Kochung Tsui,Pui-Yan Kwok,Wayne Huey-Herng Sheu,Shun-Fa Yang,Jyh-Ming Liou,Jaw-Yuan Wang,Jeng-Fong Chiou,Jer-Yuarn Wu,Cathy S.-J. Fann
DOI: https://doi.org/10.1101/2024.10.14.24315279
2024-10-15
Abstract:Predicting complex disease risks based on individual genomic profiles is an advancing field in human genetics. However, most genetic studies have focused on European populations, creating a global imbalance in precision medicine and underscoring the need for genomic research in non-European groups. The Taiwan Precision Medicine Initiative (TPMI) recruited over half a million Taiwanese residents, providing the largest datasets of genetic profiles and electronic medical records for the Han Chinese. Using extensive phenotypic data, we conducted the largest genomic analyses of Han Chinese across the medical phenome. These analyses identified population-specific genetic risk variants and novel findings on the genetic architecture of complex traits. We developed polygenic risk scores, demonstrating strong predictive performance for conditions such as cardiometabolic diseases, autoimmune disorders, cancers, and infectious diseases. We observed consistent findings in an independent dataset, Taiwan Biobank, and among East Asians in the UK Biobank and the All of Us Project. The identified genetic risks accounted for up to 9.1% of the disease burden variance in Taiwan. Our approach of characterizing the phenome-wide genomic landscape, developing population-specific risk prediction models, assessing their performance, and identifying the genetic impact on health, serves as a model for similar studies in other diverse study populations.